|
|
|
|
The Third Signal Cytokine IL-12 Rescues the Anti-Viral Function of Exhausted HBV-Specific CD8 T Cells
|
|
|
|
|
|
|
|
نویسنده
|
schurich a. ,pallett l.j. ,lubowiecki m. ,singh h.d. ,gill u.s. ,kennedy p.t. ,nastouli e. ,tanwar s. ,rosenberg w. ,maini m.k.
|
|
منبع
|
plos pathogens - 2013 - دوره : 9 - شماره : 3
|
|
چکیده
|
Optimal immune activation of naïve cd8 t cells requires signal 1 mediated by the t cell receptor,signal 2 mediated by co-stimulation and signal 3 provided by pro-inflammatory cytokines. however,the potential for signal 3 cytokines to rescue anti-viral responses in functionally exhausted t cells has not been defined. we investigated the effect of using third signal cytokines il-12 or ifn-α to rescue the exhausted cd8 t cell response characteristic of patients persistently infected with hepatitis b virus (hbv). we found that il-12,but not ifn-α,potently augmented the capacity of hbv-specific cd8 t cells to produce effector cytokines upon stimulation by cognate antigen. functional recovery mediated by il-12 was accompanied by down-modulation of the hallmark inhibitory receptor pd-1 and an increase in the transcription factor t-bet. pd-1 down-regulation was observed in hbv but not cmv-specific t cells,in line with our finding that the highly functional cmv response was not further enhanced by il-12. il-12 enhanced a number of characteristics of hbv-specific t cells important for viral control: cytotoxicity,polyfunctionality and multispecificity. furthermore,il-12 significantly decreased the pro-apoptotic molecule bim,which is capable of mediating premature attrition of hbv-specific cd8 t cells. combining il-12 with blockade of the pd-1 pathway further increased cd8 functionality in the majority of patients. these data provide new insights into the distinct signalling requirements of exhausted t cells and the potential to recover responses optimised to control persistent viral infections. © 2013 schurich et al.
|
|
|
|
|
آدرس
|
division of infection and immunity,university college london,london, United Kingdom, division of infection and immunity,university college london,london, United Kingdom, division of infection and immunity,university college london,london, United Kingdom, division of infection and immunity,university college london,london,united kingdom,centre for hepatology,university college london,london, United Kingdom, centre for digestive disease,barts,london school for medicine and dentistry,london, United Kingdom, centre for digestive disease,barts,london school for medicine and dentistry,london, United Kingdom, department of clinical microbiology and virology,university college london hospital,london, United Kingdom, centre for hepatology,university college london,london, United Kingdom, centre for hepatology,university college london,london, United Kingdom, division of infection and immunity,university college london,london, United Kingdom
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|